FILTER
FILTERED INTERVIEW RESULTS
Chris Dougherty
PRESIDENT AND CHAIRMAN, NORDMIN ENGINEERING
"Given the industry’s challenges, including cost increases and procurement delays, working as a team is essential."
Charles Kocsis
PROFESSOR & FORMER DEPARTMENT CHAIR - DEPARTMENT OF MINING ENGINEERING, THE UNIVERSITY OF UTAH
"Our focus is on advancing innovations in mine automation, efficient ventilation, mine design, and cooling systems to boost productivity and prioritize worker safety."
Donna LaVoie
FOUNDER AND CEO, LAVOIEHEALTHSCIENCE
"For biotechs, finding the balance between appealing to the public and institutional investors will be a challenge, much like trying to balance a recipe with the right mix of ingredients for the perfect dish."
Debbie Hart
PRESIDENT AND CEO, BIONJ
"New Jersey is home to eight of the top 10 global biopharmaceutical companies, nine of the top 10 R&D firms, and over 5,600 life sciences establishments. The State accounted for 43% of all novel FDA approvals in the past two years."
David Short
SR. MANAGER, BUSINESS DEVELOPMENT - US & CANADA, PROCOS S.P.A.
"Procos is poised for transformative growth in 2025. Our R11 facility will significantly enhance our small-scale production capacity, enabling us to meet the growing demand for high-quality, specialized APIs in the US market."
Eric Smith
MANAGING DIRECTOR, CEMENTATION AMERICAS
"Inflation has undoubtedly impacted mining costs across North America, especially in terms of labor and materials."
Arda Ural
PHD LIFE SCIENCES SECTOR LEADER, EY
"Heading to 2025, the outlook seems positive, particularly with US$1.3 trillion of capital available for dealmaking. This positions the industry to pursue external growth aggressively if internal pipelines fall short."
Gil Roth
PRESIDENT, PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION (PBOA)
"Early-stage R&D projects face longer timelines, making them less attractive when inflation remains high. If interest rates continue to decline, there could be increased investment in earlier-stage assets."
Eric Wasmund and Jose Marin
VICE PRESIDENT GLOBAL FLOTATION BUSINESS (EW) AND DIRECTOR – MINERALS AND MATERIAL'S PROCESSING (JW), ERIEZ
"Eriez’s collaboration gave Kennecott and Rio Tinto a competitive edge, allowing them to leverage new technology across their operations."
Greg Heiges and Peter Rowland
MINING BUSINESS DEVELOPMENT MANAGER (GH) AND CANADA SOLUTION SALES MANAGER (PR), YOKOGAWA
"Our goal is to stabilize mining operations by managing fluctuations in material quality and throughput with our control systems."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
